Evan L. Wasoff serves as Executive at Intiva BioPharma Inc., where they oversee executive responsibilities. Since joining the company, Evan L. Wasoff has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 23, 2024 involved receiving (via award) 2,000,000 shares valued at $0.
Evan L. Wasoff currently holds 6,500,000 shares of Intiva BioPharma Inc. (KDRH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Evan L. Wasoff has been a net neutral trader of KDRH stock. They have purchased $0 and sold $0 worth of shares.
Evan L. Wasoff's most recent insider trade was on May 23, 2024, when they sold 2,000,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 25, 2023 | NXEN | $0 | Award | 250,000 | $N/A | Discretionary |
| Apr 1, 2023 | NXEN | $0 | Award | 250,000 | $N/A | Discretionary |
| Jan 17, 2023 | NXEN | $0 | Award | 250,000 | $N/A | Discretionary |
| Oct 17, 2022 | NXEN | $0 | Award | 250,000 | $N/A | Discretionary |
| Jul 27, 2022 | NXEN | $0 | Award | 250,000 | $N/A | Discretionary |
| Apr 20, 2022 | NXEN | $0 | Award | 250,000 | $N/A | Discretionary |
| Jan 27, 2022 | NXEN | $0 | Award | 250,000 | $N/A | Discretionary |
| Nov 29, 2021 | NXEN | $0 | Award | 500,000 | $N/A | Discretionary |
| Apr 1, 2021 | NXEN | $0 | Award | 1,000,000 | $N/A | Discretionary |
| Nov 29, 2017 | KDRH | $0 | Other | 629,128 | $N/A | Discretionary |